BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8072892)

  • 1. [Purine analogs of the second generation in treatment of chronic lymphocytic leukemia].
    Rupniewska ZM; Dmoszyńska A; Roliński J
    Pol Arch Med Wewn; 1994 Apr; 91(4):302-10. PubMed ID: 8072892
    [No Abstract]   [Full Text] [Related]  

  • 2. [Purine analogs in chronic lymphatic leukemia].
    Ellegaard J
    Ugeskr Laeger; 1996 Nov; 158(45):6413. PubMed ID: 8992673
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of advanced chronic lymphocytic leukemia.
    Cao TM; Coutre SE
    Curr Hematol Rep; 2003 Jan; 2(1):65-72. PubMed ID: 12901156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
    Robak T
    Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idelalisib for chronic lymphocytic leukemia.
    Brown JR
    Clin Adv Hematol Oncol; 2014 Dec; 12(12):846-8. PubMed ID: 25674842
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemoimmunotherapy of chronic lymphocytic leukemia.
    Tam CS; Keating MJ
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):479-98. PubMed ID: 17707835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient hypophysitis in a patient treated by duvelisib for chronic lymphocytic leukemia.
    Orioli L; Sarti K; Van Den Neste E; Maiter D
    Ann Hematol; 2017 Apr; 96(4):685-686. PubMed ID: 28150013
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinase inhibitors overachieve in CLL.
    Garber K
    Nat Rev Drug Discov; 2014 Mar; 13(3):162-4. PubMed ID: 24549135
    [No Abstract]   [Full Text] [Related]  

  • 9. Idelalisib for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Barrientos JC
    Future Oncol; 2016 Sep; 12(18):2077-94. PubMed ID: 27324214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IPI-145 shows promise in CLL patients.
    Cancer Discov; 2014 Feb; 4(2):136. PubMed ID: 24501284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purine analogs in the treatment of chronic lymphocytic leukemia.
    Pott C; Hiddemann W
    Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising results Halt phase III studies of idelalisib.
    Inman S
    Am J Manag Care; 2014 Feb; 20(2 Spec No.):E9. PubMed ID: 25764575
    [No Abstract]   [Full Text] [Related]  

  • 13. Perspectives on purine analogues.
    Cheson BD
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S109-16. PubMed ID: 9137964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retreatment with purine analogs in patients with chronic lymphocytic leukemia.
    Dlouhy I; Ghita G; Baumann T; Gine E; Villamor N; Rozman M; Martinez-Trillos A; Lopez-Guillermo A; Delgado J
    Leuk Res; 2012 Dec; 36(12):1521-5. PubMed ID: 22938831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing paradigms in the treatment of chronic lymphocytic leukemia.
    Foon KA; Hallek MJ
    Leukemia; 2010 Mar; 24(3):500-11. PubMed ID: 20033051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of chronic lymphatic leukemia].
    Adam Z; Vorlícek J; Hejlová N
    Vnitr Lek; 1996 Aug; 42(8):573-8. PubMed ID: 8967031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of stem-cell transplantation in chronic lymphocytic leukemia risk-adapted therapy.
    Giné E; Moreno C; Esteve J; Montserrat E
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):529-43. PubMed ID: 17707838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide.
    Zolnierczyk JD; Błoński JZ; Robak T; Kiliańska ZM; Wesierska-Gadek J
    Ann N Y Acad Sci; 2009 Aug; 1171():124-31. PubMed ID: 19723046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Danazol induces apoptosis and cytotoxicity of leukemic cells alone and in combination with purine nucleoside analogs in chronic lymphocytic leukemia.
    Podhorecka M; Macheta A; Chocholska S; Bojarska-Junak A; Szymczyk A; Goracy A; Dmoszynska A; Hus M
    Ann Hematol; 2016 Feb; 95(3):425-35. PubMed ID: 26692089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.